New insights are enhancing scientists' efforts to stay ahead of COVID-19 and the next pandemic.
Unexpected new insights into the ways COVID-19 infects cells could shed light on the virus's adept ability to jump from one species to another and assist scientists in more accurately predicting its evolution.
The pandemic has been marked by extensive debate regarding the mechanism by which COVID-19 invades cells, largely focusing on its use of a human cell protein known as ACE2. However, recent research from the University of Virginia School of Medicine reveals that ACE2 isn't required for infection. Instead, the virus has other means it can use to infect cells.
That versatility suggests that coronaviruses can use multiple "doors" to enter cells, potentially explaining how they are so good at infecting different species.

Researcher Peter Kasson, MD, PhD, of the University of Virginia School of Medicine. Credit: UVA Health
Understanding COVID-19
COVID-19 has killed almost 7 million people around the world. Thankfully, the availability of vaccines and the increase in population immunity means that the virus is no longer the threat it once was to most people (though it remains a concern for groups such as the immunocompromised and elderly). With the expiration of the United States' official Public Health Emergency in May, most Americans have largely returned to lives similar to the ones they knew before the pandemic emerged in 2019. But COVID-19 continues to evolve and change, and scientists are keeping a close eye on it so that they can take quick action if a more dangerous variant emerges. They also continue to monitor other coronaviruses in case they jump to humans and become the next great public health threat.
As part of this effort, Kasson and his team wanted to better understand how the virus responsible for COVID-19, SARS-CoV-2, can enter human cells. Scientists have known that the virus essentially knocks on the cell's door by binding to ACE2 proteins. These proteins are bountiful on the surfaces of cells lining the nose and lungs.
SARS-CoV-2 can also bind with other proteins, however. Was it possible, the scientists wondered, that it could use those other proteins to infiltrate cells? The answer was yes. ACE-2 was the most efficient route, but it was not the only route. And that suggests that the virus can bind and infect even cells without any ACE-2 receptors at all.
That unexpected finding may help explain why coronaviruses are so adept at species-hopping, Kasson says. And that makes it even more important that scientists keep a close eye on them, he notes.
"Coronaviruses like SARS-CoV-2 have already caused one pandemic and several near misses that we know of," he said. "That suggests there are more out there, and we need to learn how they spread and what to watch out for."
Reference: "The ACE2 receptor accelerates but is not biochemically required for SARS-CoV-2 membrane fusion" by Marcos Cervantes, Tobin Hess, Giorgio G. Morbioli, Anjali Sengara and Peter M. Kasson, 5 June 2023, Chemical Science.
DOI: 10.1039/D2SC06967A
The study was funded by the Commonwealth Health Research Board, grant 207-01-18; UVA's Global Infectious Diseases Institute; and the Knut and Alice Wallenberg Foundation, grant KAW2020.0209.
News
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Ebola kills 2,300 in three months with no vaccine available for Congo’s deadliest ever outbreak
It’s Congo’s 17th outbreak, with a toll that has eclipsed that of the country’s 2018-2020 outbreak when 2,299 deaths out of 3,481 cases were recorded. The latest data shows 101 new cases and 33 [...]
Beyond an Agency: How AI, Creativity and Commercialization Are Converging Into a New Growth Model
At a moment when AI is forcing a fundamental rethink of how work gets done, the life sciences industry is grappling with a deeper question: what role should human creativity play in an increasingly [...]
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing
A simple blood test that detects chemical changes in DNA identified more than 90% of stage 2-4 lung cancers in an early study, without relying on costly DNA sequencing. Researchers at Tel Aviv University and collaborating [...]
Reducing drug development failures with human-relevant models and AI
Professor Joseph C. Wu of Stanford University explains how stem cells, human-relevant models and AI are helping researchers predict which drug candidates are most likely to succeed before clinical trials. Researchers now have access [...]
Half of vaccines are binned – ‘fridge-free’ versions could change that
Vaccines that do not need to be kept cool in a fridge have been successfully trialed in patients for the first time, say UK scientists. Currently, most vaccines need to be refrigerated or frozen [...]
Mushroom Mystery: The Fungus That Makes People See Tiny Humans
A mushroom sold in markets and served in restaurants in Southwest China has an unusual warning attached to it: cook it thoroughly, or you may start seeing tiny people. For decades, people have reported [...]
Artificial intelligence used to design brand new viruses
Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers. It is the first time whole genomes have been successfully designed [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]















